RU2012155738A - COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSING OXIDATIVE STRESS IN TYPE 2 DIABETES - Google Patents

COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSING OXIDATIVE STRESS IN TYPE 2 DIABETES Download PDF

Info

Publication number
RU2012155738A
RU2012155738A RU2012155738/15A RU2012155738A RU2012155738A RU 2012155738 A RU2012155738 A RU 2012155738A RU 2012155738/15 A RU2012155738/15 A RU 2012155738/15A RU 2012155738 A RU2012155738 A RU 2012155738A RU 2012155738 A RU2012155738 A RU 2012155738A
Authority
RU
Russia
Prior art keywords
composition
diabetes
type
oxidative stress
aimed
Prior art date
Application number
RU2012155738/15A
Other languages
Russian (ru)
Other versions
RU2535069C2 (en
Inventor
Владимир Владимирович Дынник
Людмила Петровна Долгачева
Валерий Петрович Зинченко
Александр Игоревич Сергеев
Мария Александровна Симонова
Николай Петрович Сирота
Анна Владимировна Толмачева
Original Assignee
Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН) filed Critical Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН)
Priority to RU2012155738/15A priority Critical patent/RU2535069C2/en
Publication of RU2012155738A publication Critical patent/RU2012155738A/en
Application granted granted Critical
Publication of RU2535069C2 publication Critical patent/RU2535069C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа, содержащая в расчете на 1 дозу: коэнзим Q10 50-120 мг, дигидрокверцитин 30-160 мг, А-липоевую кислоту 30-60 мг.2. Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа, содержащая в расчете на 1 дозу: коэнзим Q10 50-100 мг, дигидрокверцитин 50-100 мг, А-липоевую кислоту 30-60 мг, никотинамид 50-100 мг.1. The composition of the antioxidant composition aimed at suppressing oxidative stress in type 2 diabetes, containing per dose: Coenzyme Q10 50-120 mg, dihydroquercytin 30-160 mg, A-lipoic acid 30-60 mg. 2. Composition of an antioxidant composition aimed at suppressing oxidative stress in type 2 diabetes, containing per dose: Coenzyme Q10 50-100 mg, dihydroquercytin 50-100 mg, A-lipoic acid 30-60 mg, nicotinamide 50-100 mg.

Claims (2)

1. Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа, содержащая в расчете на 1 дозу: коэнзим Q10 50-120 мг, дигидрокверцитин 30-160 мг, А-липоевую кислоту 30-60 мг.1. The composition of the antioxidant composition aimed at suppressing oxidative stress in type 2 diabetes, containing per dose: Coenzyme Q10 50-120 mg, dihydroquercytin 30-160 mg, A-lipoic acid 30-60 mg. 2. Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа, содержащая в расчете на 1 дозу: коэнзим Q10 50-100 мг, дигидрокверцитин 50-100 мг, А-липоевую кислоту 30-60 мг, никотинамид 50-100 мг. 2. The composition of the antioxidant composition aimed at suppressing oxidative stress in type 2 diabetes, containing per dose: coenzyme Q10 50-100 mg, dihydroquercytin 50-100 mg, A-lipoic acid 30-60 mg, nicotinamide 50-100 mg .
RU2012155738/15A 2012-12-21 2012-12-21 Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes RU2535069C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012155738/15A RU2535069C2 (en) 2012-12-21 2012-12-21 Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012155738/15A RU2535069C2 (en) 2012-12-21 2012-12-21 Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes

Publications (2)

Publication Number Publication Date
RU2012155738A true RU2012155738A (en) 2014-06-27
RU2535069C2 RU2535069C2 (en) 2014-12-10

Family

ID=51215976

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012155738/15A RU2535069C2 (en) 2012-12-21 2012-12-21 Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes

Country Status (1)

Country Link
RU (1) RU2535069C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123350C1 (en) * 1997-12-30 1998-12-20 Борщев Александр Николаевич Phytoconcentrate of curative-prophylactic effect for patients with diabetes mellitus
AU5142699A (en) * 1998-07-31 2000-02-28 Mount Sinai Hospital Corporation Methods and compositions for increasing insulin sensitivity
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
CN101982115A (en) * 2010-10-14 2011-03-02 张丽娜 Composite for preventing and curing diabetes chronic sugar poisoning

Also Published As

Publication number Publication date
RU2535069C2 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
WO2014039903A3 (en) Stable aqueous formulations of adalimumab
IL233200A0 (en) Alpha-amino boronic acid derivatives, their preparation and pharmaceutical compositions containing them
PH12015500900B1 (en) A stabilized pemetrexed formulation
MX2014004725A (en) Etanercept formulations stabilized with amino acids.
GB201106743D0 (en) Novel compounds
WO2012104007A3 (en) 7-azaindole derivatives
PH12015501609A1 (en) Phenicol antibacterials
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
MX2019013776A (en) Treatment of solid tumors using coenzyme q10.
WO2014039533A3 (en) Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
MX2013013649A (en) Quinone compounds for treating ape1 mediated diseases.
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
MX342417B (en) Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs.
RU2012155738A (en) COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSING OXIDATIVE STRESS IN TYPE 2 DIABETES
MY187748A (en) Compositions and method for maintaining/improving cognitive function
WO2014011680A3 (en) Tetrahydro-isohumulone derivatives, methods of making and using
MY172749A (en) Use of cell wall disrupted product of chlorella for reducing serum resistin level
IN2015DN02660A (en)
MX2015004316A (en) Flavor and fragrance formulation (iv).
UA92872C2 (en) combined antiaggregate and antioxidant drug
RU2011100853A (en) ASTAXANTINE FOR DENTAL MEDICINES
UA66165U (en) use of vitamin composition that contains vitamins C and K3, as means for treatment of viral infections
MX2011003390A (en) Compound and compositions useful for treating heart diseases with reduced side effects.
UA71209U (en) (8-n-benzylaminotheophyllinyl-7)acetic acid (1-phenylethylidene)hydrazide exhibiting antioxidant activity
UA80812U (en) ETHYL 6-THIOXO-3-(2-FURYLMETHYL)-7-CYANO-1,3,4,6-2H-PYRIDO[1,2-a][1,3,5]TRIAZINE -9-CARBOXYLATE

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant